NOVOSITE THERAPEUTICS Trademark
Trademark Overview
On Tuesday, April 2, 2024, a trademark application was filed for NOVOSITE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOVOSITE THERAPEUTICS trademark a serial number of 98480811. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, October 16, 2024. This trademark is owned by Site TX, Inc.. The NOVOSITE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation
General Information
| Serial Number | 98480811 |
| Word Mark | NOVOSITE THERAPEUTICS |
| Filing Date | Tuesday, April 2, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Wednesday, October 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Site TX, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dover, DE 19904 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 2, 2024 | NEW APPLICATION ENTERED |
| Sunday, September 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 16, 2024 | ASSIGNED TO EXAMINER |
